| Literature DB >> 30149586 |
János Sándor1, Anita Pálinkás2, Ferenc Vincze3, Nóra Kovács4, Valéria Sipos5, László Kőrösi6, Zsófia Falusi7, László Pál8, Gergely Fürjes9, Magor Papp10, Róza Ádány11,12,13.
Abstract
Roma is the largest ethnic minority of Europe with deprived health status, which is poorly explored due to legal constrains of ethnicity assessment. We aimed to elaborate health indicators for adults living in segregated Roma settlements (SRS), representing the most vulnerable Roma subpopulation. SRSs were mapped in a study area populated by 54,682 adults. Records of all adults living in the study area were processed in the National Institute of Health Insurance Fund Management. Aggregated, age-sex standardized SRS-specific and non-SRS-specific indicators on healthcare utilization and all-cause premature death along with the ratio of them (RR) were computed with 95% confidence intervals. The rate of GP appointments was significantly higher among SRS inhabitants (RR = 1.152, 95% CI: 1.136⁻1.167). The proportion of subjects hospitalized (RR = 1.286, 95% CI: 1.177⁻1.405) and the reimbursement for inpatient care (RR = 1.060, 95% CI: 1.057⁻1.064) were elevated for SRS. All-cause premature mortality was significantly higher in SRSs (RR = 1.711, 1.085⁻2.696). Our study demonstrated that it is possible to compute the SRS-specific version of routine healthcare indicators without violating the protection of personal data by converting a sensitive ethical issue into a non-sensitive small-area geographical analysis; there is an SRS-specific healthcare utilization pattern, which is associated with elevated costs and increased risk of all-cause premature death.Entities:
Keywords: Roma minority; geographical inequality; health status; healthcare utilization; legal constraints
Mesh:
Year: 2018 PMID: 30149586 PMCID: PMC6163424 DOI: 10.3390/ijerph15091835
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Pathway, performance and all-cause premature mortality indicators for adults living in segregated Roma settlements (SRSs) and living in the same municipalities’ complementary areas (non-SRSs) with the age- and sex-standardized relative rates (RRs) in care for inhabitants of SRSs.
| Indicator Type | Indicator Name |
|---|---|
| pathway indicators | number of GP appointments per person per year |
| proportion of subjects receiving outpatient care per year | |
| number of interventions in outpatient care per person per year | |
| reimbursement for interventions in outpatient care per person per year | |
| proportion of subjects hospitalized per year | |
| duration of hospitalization in inpatient care per person per year | |
| reimbursement for inpatient care per person per year | |
| proportion of subjects having an imaging examination per year | |
| total number of imaging examinations per person per year | |
| reimbursement for imaging examination in outpatient care per person per year | |
| performance indicators | proportion of patients above 65 years of age vaccinated against influenza within the last 12 months |
| proportion of patients aged 40–54 years with treated hypertension (taking antihypertensive medication at least four times within 12 months) | |
| proportion of patients aged 55–69 years with treated hypertension (taking antihypertensive medication at least four times within 12 months) | |
| proportion of patients having a serum creatinine test within the last 12 months among treated hypertensive patients (taking antihypertensive drugs at least four times within the last 12 months) | |
| proportion of patients having a lipid status assessment within the last 12 months among treated hypertensive and/or treated diabetes patients (taking antihypertensive medication at least four times within 12 months and/or taking ATC code A10 drugs at least four times within the last 12 months) | |
| proportion of patients taking beta-blocker medication at least four times within 12 months relative to the total number of acute myocardial infarction (MI) and/or coronary artery bypass surgery (CABG) and/or percutaneous coronary intervention (PTCA) patients | |
| proportion of patients among treated diabetes patients having a hemoglobin A1c test within the last 12 months (taking ATC code A10 drugs at least four times within the last 12 months) | |
| proportion of patients among treated diabetes patients examined by ophthalmologist within the last 12 months (taking ATC code A10 drugs at least four times within the last 12 months) | |
| proportion of patients aged 40–54 years with treated diabetes mellitus (taking ATC code A10 drugs at least four times within 12 months) | |
| proportion of patients aged 55–69 years with treated diabetes mellitus (taking ATC code A10 drugs at least four times within 12 months) | |
| per capita amount of purchased antibiotics prescribed by the GP, in the previous 12 months | |
| participation rate of mammography in the previous 24 months among 45- to 65-year-old women | |
| participation rate of cervical cytology in the previous 36 months among 25- to 65-year-old women | |
| all-cause premature mortality | mortality rate for adults 18–64 years old who had not changed GMPs in the five years prior to the investigated year |
Figure 1Data processing to produce routine Roma-specific primary care indicators for adults (by utilizing available administrative databases of the National Institute of Health Insurance Fund Management with avoiding person-level identification of Roma people; light gray-shaded input data; dark gray-shaded output data).
Figure 2Distribution of age groups in the studied Roma and non-Roma populations.
Service delivery rates as pathway indicators for adults living in segregated Roma settlements (SRSs) and living in the same municipalities’ complementary areas (non-SRSs) with the age- and sex-standardized relative service delivery rates (RRs) for inhabitants of SRSs.
| Indicators | Crude Rates in the Sample, N (%) | SRS | Non-SRS | RR [95% CI] | ||
|---|---|---|---|---|---|---|
| N | Standardized Rates [95% CI] | N | Standardized Rates [95% CI] | |||
| number of GP appointments (appointments per capita per year) | 454,257 (8.31) | 22,322 | 1.144 [1.129–1.159] | 431,935 | 0.994 [0.991–0.996] | 1.152 [1.136–1.167] |
| number of subjects receiving outpatient care at least once a year (%) | 40,255 (73.62) | 2059 | 0.97 [0.929–1.012] | 38,196 | 1.002 [0.992–1.012] | 0.968 [0.926–1.012] |
| number of interventions in outpatient care a year (interventions per capita) | 1,834,015 (33.54) | 76,715 | 0.897 [0.891–0.904] | 1,757,300 | 1.005 [1.004–1.007] | 0.893 [0.886–0.899] |
| reimbursement in outpatient care a year (EURO per capita) | 2,011,662 (36.79) | 87,311 | 0.924 [0.918–0.930] | 1,924,351 | 1.004 [1.002–1.005] | 0.920 [0.914–0.927] |
| number of subjects having imaging examination at least once a year (%) | 28,629 (52.36) | 1556 | 1.061 [1.009–1.115] | 27,073 | 0.997 [0.985–1.009] | 1.064 [1.011–1.120] |
| number of imaging examinations a year (examinations per capita) | 1,076,117 (19.68) | 44,413 | 0.899 [0.891–0.908] | 1,031,704 | 1.005 [1.003–1.007] | 0.895 [0.887–0.904] |
| reimbursement for imaging examination a year (EURO per capita) | 703,974 (12.87) | 34,139 | 1.034 [1.023–1.046] | 669,835 | 0.998 [0.996–1.001] | 1.036 [1.025–1.047] |
| number of subjects being hospitalized at least once a year (%) | 9007 (16.47) | 522 | 1.269 [1.165–1.383] | 8,485 | 0.987 [0.966–1.008] | 1.286 [1.177–1.405] |
| duration of hospitalization a year (days per capita) | 142,475 (2.61) | 58,265 | 1.162 [1.132–1.192] | 136,649 | 0.994 [0.989–0.999] | 1.168 [1.138–1.200] |
| reimbursement in inpatient care a year (EURO per capita) | 7,554,882 (138.16) | 299,580 | 1.058 [1.054–1.061] | 7,255,301 | 0.9977 [0.9970–0.9984] | 1.060 [1.057–1.064] |
Service delivery rates as performance indicators for adults living in segregated Roma settlements (SRSs) and living in the same municipalities’ complementary areas (non-SRSs) with the age- and sex-standardized relative service delivery rates (RRs) for inhabitants of SRSs.
| Indicators | Crude Rates in the Sample, N (%) | SRS | Non-SRS | RR [95% CI] | ||
|---|---|---|---|---|---|---|
| N | Standardized Rates [95% CI] | N | Standardized Rates [95% CI] | |||
| influenza vaccination, above 65 years of age | 2523 (23.22) | 29 | 0.679 [0.472–0.977] | 2494 | 1.006 [0.967–1.046] | 0.675 [0.468–0.973] |
| prevalence of hypertension, 40–54 years | 3461 (25.57) | 200 | 0.999 [0.870–1.148] | 3261 | 1.000 [0.966–1.035] | 0.999 [0.866–1.153] |
| prevalence of hypertension, 55–69 years | 6938 (55.99) | 200 | 0.916 [0.798–1.053] | 6738 | 1.003 [0.979–1.027] | 0.914 [0.794–1.052] |
| Serum-creatinine assessment, hypertension | 10447 (60.99) | 309 | 0.964 [0.863–1.078] | 10,138 | 1.001 [0.982–1.021] | 0.963 [0.860–1.079] |
| lipid status check-up, hypertension and/or diabetes | 9666 (54.73) | 324 | 1.067 [0.957–1.189] | 9342 | 0.998 [0.978–1.018] | 1.069 [0.957–1.194] |
| beta–blocker, ischemic heart diseases | 523 (51.73) | 23 | 1.049 [0.697–1.579] | 500 | 0.998 [0.914–1.089] | 1.052 [0.692–1.597] |
| HbA1c check-up, diabetes | 2674 (73.64) | 82 | 0.817 [0.658–1.015] | 2592 | 1.007 [0.969–1.047] | 0.811 [0.651–1.011] |
| ophthalmologic check-up, diabetes | 1313 (36.16) | 34 | 0.701 [0.501–0.982] | 1279 | 1.011 [0.958–1.068] | 0.693 [0.493–0.975] |
| prevalence of diabetes, 40–54 years | 618 (4.57) | 40 | 1.123 [0.824–1.531] | 578 | 0.992 [0.915–1.077] | 1.132 [0.821–1.559] |
| prevalence of diabetes, 55–69 years | 1241 (10.01) | 36 | 0.929 [0.670–1.287] | 1205 | 1.002 [0.947–1.061] | 0.927 [0.665–1.291] |
| treatment with antibiotics | 13371 (24.49) | 570 | 0.791 [0.728–0.858] | 12,801 | 1.012 [0.995–1.030] | 0.781 [0.718–0.850] |
| mammography, 45–64 years | 4451 (47.96) | 76 | 0.392 [0.313–0.490] | 4375 | 1.028 [0.998–1.059] | 0.381 [0.304–0.478] |
| cervix cytology, 25–64 years | 7365 (40.22) | 428 | 0.959 [0.873–1.055] | 6937 | 1.003 [0.979–1.027] | 0.957 [0.868–1.055] |